Trulicity and Mesalamine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Trulicity (dulaglutide) and Mesalamine (mesalamine). Common drug interactions include anaemia among females and atrial fibrillation among males.

The phase IV clinical study analyzes what interactions people have when they take Trulicity and Mesalamine. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Trulicity?

Trulicity has active ingredients of dulaglutide. It is often used in weight loss. eHealthMe is studying from 77,529 Trulicity users. Check the latest studies of Trulicity.

What is Mesalamine?

Mesalamine has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 28,053 Mesalamine users. Check the latest studies of Mesalamine.

On Jul, 14, 2026

21 people who take Trulicity and Mesalamine together, and have interactions are studied.

Trulicity and Mesalamine drug interactions.

What are the common drug interactions of Trulicity and Mesalamine, by gender? *:

female:

Anaemia (lack of blood)
Cough
Nephrolithiasis (calculi in the kidneys)
Pain
Pancreatitis (inflammation of pancreas)
Productive cough
Retching (strong involuntary effort to vomit)
Upper-airway cough syndrome
Abdominal pain
Anaphylactic reaction (serious allergic reaction)

male:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Asthenia (weakness)
Death
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Fatigue (feeling of tiredness)
Hypertension (high blood pressure)
Lung disorder (lung disease)
Mobility decreased (ability to move is reduced)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Nasopharyngitis (inflammation of the nasopharynx)

What are the common drug interactions of Trulicity and Mesalamine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Abdominal pain
Drug hypersensitivity
Eructation (release of gas from the digestive tract)
Flatulence (flatus expelled through the anus)
Nausea (feeling of having an urge to vomit)
Urticaria (rash of round, red welts on the skin that itch intensely)

50-59:

Asthenia (weakness)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Blood pressure decreased
Dizziness
Hyperhidrosis (abnormally increased sweating)
Pain
Pyrexia (fever)
Blood pressure increased
Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)

60+:

Death
Sepsis (a severe blood infection that can lead to organ failure and death)
Injection site reaction
Mobility decreased (ability to move is reduced)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Nausea (feeling of having an urge to vomit)
Pneumonia
Procedural pain
Rectal haemorrhage (bleeding from anus)
Troponin increased

What are the existing conditions these people have? *

Diabetes: 11 people, 52.38%
High Blood Cholesterol: 8 people, 38.10%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 23.81%
Anaemia (lack of blood): 5 people, 23.81%
High Blood Pressure: 4 people, 19.05%
Blood Pressure Abnormal: 4 people, 19.05%
Prostate Cancer: 2 people, 9.52%
Nausea (feeling of having an urge to vomit): 2 people, 9.52%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Trulicity and Mesalamine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously